Min Jaewon, Wright Woodring E, Shay Jerry W
Department of Cell Biology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-9039, USA.
Nucleic Acids Res. 2017 Mar 17;45(5):2615-2628. doi: 10.1093/nar/gkw1295.
Alternative lengthening of telomeres (ALT) is a telomerase independent telomere maintenance mechanism that occurs in ∼15% of cancers. The potential mechanism of ALT is homology-directed telomere synthesis, but molecular mechanisms of how ALT maintains telomere length in human cancer is poorly understood. Here, we generated TERC (telomerase RNA) gene knockouts in telomerase positive cell lines that resulted in long-term surviving clones acquiring the ALT pathway but at a very low frequency. By comparing these ALT cells with parental telomerase positive cells, we observed that ALT cells possess excessively long telomeric overhangs derived from telomere elongation processes that mostly occur during S phase. ALT cells exhibited preferential elongation of the telomeric lagging strands, whereas telomerase positive cells exhibited similar elongation between leading and lagging strands. We propose that the ALT pathway preferentially occurs at telomeric lagging strands leading to heterogeneous telomere lengths observed in most ALT cancers.
端粒替代延长(ALT)是一种不依赖端粒酶的端粒维持机制,约15%的癌症中会出现这种机制。ALT的潜在机制是同源定向端粒合成,但对于ALT如何在人类癌症中维持端粒长度的分子机制了解甚少。在这里,我们在端粒酶阳性细胞系中产生了TERC(端粒酶RNA)基因敲除,导致长期存活的克隆以非常低的频率获得ALT途径。通过将这些ALT细胞与亲代端粒酶阳性细胞进行比较,我们观察到ALT细胞拥有源自端粒延长过程的过长端粒悬突,这些过程大多发生在S期。ALT细胞表现出端粒滞后链的优先延长,而端粒酶阳性细胞在前导链和滞后链之间表现出相似的延长。我们提出,ALT途径优先发生在端粒滞后链上,导致在大多数ALT癌症中观察到的端粒长度异质性。